![]() Indian Express |
![]() Express India |
![]() Screen |
![]() Loksatta |
![]() Express Cricket |
![]() Kashmir Live |
![]() Biz Publications |




safer anti-cancer drug may be based on better purification methods, use the principles of lipid chemistry as well as polymers to deliver tiny microgram doses to the tumour site.
In the present scenario, some
Indian firms are developing novel drug delivery systems for the existing molecules—to control the rate at which a drug dissolves in the blood—and out-license the same to the original patent holders. NDDS help the originators extend the life of the existing product patents and in return, more money to the company that develops the same. Perhaps, Baldota best summarises the mood in the marketplace, “In the future, one would likely see many new delivery systems, based on interesting technologies in the international market, where the IP is owned by an Indian company.”...
| Single Page Format | Previous - 1 - 2 - 3 - 4 |
Discuss this story on expressindia forums
|
|
Most Read Articles![]() |
![]() |
![]() |

© 2008: Indian Express Newspapers (Mumbai) Ltd. All rights reserved throughout the world